Faculty Opinions recommendation of Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
2012 ◽
Vol 160
(3)
◽
pp. 213-214
◽
2018 ◽
Vol 11
(9)
◽
pp. 915-917
◽
2013 ◽
Vol 61
(20)
◽
pp. 2048-2055
◽
2011 ◽
Vol 77
(2)
◽
pp. 174-181
◽
2019 ◽
Vol 73
(15)
◽
pp. S14-S15